Boston Medical Center (BMC) Grayken Center for Addiction Training and Technical Assistance (TTA)

A Resource for Healthcare and Social Services Professionals

Medications for AUD: Acamprosate and Disulfiram

August 11, 2022
4:00 pm–4:30 pm ET

This training will review the basic pharmacology and clinical uses for both acamprosate and disulfiram in the treatment of alcohol use disorders.

Register now

Virtual meeting

Via Zoom

Description

AUD Series: These trainings will provide an overview of alcohol use disorders, evidence-based screening tools, brief negotiated interview (BNI) for alcohol consumption, management of AUD in the primary care setting, and medications for the treatment of alcohol use disorder. 

This training will review the basic pharmacology and clinical uses for both acamprosate and disulfiram in the treatment of alcohol use disorders.

Intended audience

Nurses, social workers, other clinical staff, and non-clinicians.

Speakers

Joseph Boyle, MD

Objectives

Sponsored by

Boston Medical Center Grayken Center for Addiction TTA, Department of Public Health, Bureau of Substance Addiction Services (BSAS/DPH)

Funding for out of state attendees is provided by the Opioid Response Network (ORN). 

Funding for this initiative was made possible (in part) by grant no. 1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Accreditation information

Boston Medical Center grants 0.50 hours to all nurses who attend and complete the evaluation. Boston Medical Center is approved as a provider of continuing professional development by American Nurses Association, Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Boston University School of Medicine designates this live activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Grayken Center of Addiction TTA has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7188. Programs that do not qualify for NBCC credit are clearly identified. BMC Grayken Center of Addiction TTA is solely responsible for all aspects of the programs.

Register now

Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.

Funding for Grayken Center for Addiction TTA is provided by:

Massachusetts Department of Public Health Bureau of Substance Abuse Services (BSAS)
GE Foundation
Opioid Response Network

© 2022 Boston Medical Center. All rights reserved. Site by Signal.